Basics TransCode Therapeutics, Inc. IPO Date: July 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $7.9M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 5.92% Avg Daily Range (30 D): $0.33 | 3.18% Avg Daily Range (90 D): $0.42 | 3.63% Institutional Daily Volume Avg Daily Volume: 1.6M Avg Daily Volume (30 D): .01M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 276 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 29 Institutional Trades Total Inst.Trades: 16 Avg Inst. Trade: $.76M Avg Inst. Trade (30 D): $.57M Avg Inst. Trade (90 D): $.57M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $.65M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Oct 8, 2025 @ 2:48 PM TransCode Makes Bold Bet On Melanoma Vaccine With ... Source: Triveni Kothapalli May 5, 2025 @ 10:27 AM US Stocks Likely To Open Lower After S&P 500's 9-D... Source: Rishabh Mishra Jul 23, 2024 @ 5:26 PM Why Transcode Therapeutics (RNAZ) Stock Is Down 60... Source: Henry Khederian Jun 10, 2024 @ 12:07 PM Beat the Market Like Zacks: Goldman Sachs, Micron,... Source: Abhinab Dasgupta Jun 10, 2024 @ 11:00 AM Nasdaq Determines That TransCode Therapeutics Has ... Source: TransCode Therapeutics, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $1057.29 $-5.82 $-5.13 Diluted EPS $1057.29 $-5.82 $-5.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -27.13M $ -4.86M $ -4.28M Operating Income / Loss $ -17.05M $ -4.56M $ -4.22M Cost of Revenue $ $ $ Net Cash Flow $ 3.94M $ M $ M PE Ratio 0.01     Splits May 15, 2025:   1:28 Dec 04, 2024:   1:33 Jan 16, 2024:   1:40 May 23, 2023:   1:20